Article
Increased Efficiency for Biallelic Mutations of the CCR5 Gene by CRISPR-Cas9 Using Multiple Guide RNAs As a Novel Therapeutic Option for Human Immunodeficiency Virus.
The CRISPR journal - 1 Feb 2021
Lin Dong, Scheller Stefan H, Robinson Madeline M, Izadpanah Reza, Alt Eckhard U, Braun Stephen E
Abstract excerpt
CCR5 is a coreceptor of human immunodeficiency virus type 1 (HIV-1). Transplantation of hematopoietic stem cells homozygous for a 32-bp deletion in CCR5 resulted in a loss of detectable HIV-1 in two patients, suggesting that genetic strategies to knockout CCR5 expression would be a promising gene therapy approach for HIV-1-infected patients. In this study, we targeted CCR5 by CRISPR-Cas9 with a single-guide...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.